R Mark Adams News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from R mark adams. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In R Mark Adams Today - Breaking & Trending Today

Jennison Associates LLC Purchases 20,745 Shares of Adaptive Biotechnologies Co. (NASDAQ:ADPT)

Jennison Associates LLC increased its position in shares of Adaptive Biotechnologies Co. (NASDAQ:ADPT – Get Rating) by 11.9% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 195,036 shares of the company’s stock after acquiring an additional 20,745 shares during the period. Jennison Associates LLC […] ....

Harlan Robins , Julie Rubinstein , R Mark Adams , Piper Sandler , Adaptive Biotechnologies Corp , Jennison Associates , Exchange Commission , Credit Suisse Group , Allspring Global Investments Holdings , Sumitomo Mitsui Trust Holdings Inc , Bouvel Investment Partners , Morgan Stanley , Adaptive Biotechnologies Co , Adaptive Biotechnologies , Get Rating , Mitsui Trust Holdings , Global Investments Holdings , Water Life Science Advisors , Investment Partners , Suisse Group , President Julie Rubinstein , Mark Adams , Chad Robins , Chris Carlson , Visit Holdingschannel , Adaptive Biotechnologies Daily ,

Adaptive Biotechnologies (NASDAQ:ADPT) Price Target Raised to $15.00

Adaptive Biotechnologies (NASDAQ:ADPT – Get Rating) had its target price lifted by Piper Sandler from $14.00 to $15.00 in a report released on Monday morning, The Fly reports. A number of other analysts also recently issued reports on ADPT. Credit Suisse Group reiterated an underperform rating and issued a $7.00 price target on shares of […] ....

Julie Rubinstein , Piper Sandler , R Mark Adams , Harlan Robins , Meeder Asset Management Inc , Financial Services Group Inc , Adaptive Biotechnologies Corp , Morgan Stanley , Manchester Capital Management , Allspring Global Investments Holdings , Credit Suisse Group , Adaptive Biotechnologies , Get Rating , Suisse Group , President Julie Rubinstein , Mark Adams , Asset Management , Capital Management , Global Investments Holdings , Services Group , Chad Robins , Chris Carlson , Adaptive Biotechnologies Daily , Nasdaq Adpt , Boost Price Target ,

Adaptive Biotechnologies (NASDAQ:ADPT) Issues Earnings Results

Adaptive Biotechnologies (NASDAQ:ADPT – Get Rating) released its earnings results on Wednesday. The company reported ($0.40) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.34) by ($0.06), Briefing.com reports. The firm had revenue of $37.65 million during the quarter, compared to analyst estimates of $36.81 million. Adaptive Biotechnologies had a negative return […] ....

R Mark Adams , Harlan Robins , Stacyl Taylor , Credit Suisse Group , Morgan Stanley , Adaptive Biotechnologies Company Profile , Adaptive Biotechnologies Corp , Vident Investment Advisory , Securities Exchange Commission , Royal Bank , Adaptive Biotechnologies , Get Rating , Exchange Commission , Mark Adams , Investment Advisory , Suisse Group , Chad Robins , Chris Carlson , Adaptive Biotechnologies Daily , Nasdaq Adpt ,